Home Cannabis Cronos Group: The Catalyst for Altria's Earnings

Cronos Group: The Catalyst for Altria’s Earnings

Altria rises

Altria (MO) reported its earnings on January 31. Since the company’s earnings, the stock has gained nearly 3.2% as of February 4. The company has become a center of attention amid the surge in the cannabis industry with Altria acquiring a 45% stake in Cronos Group (CRON). Cronos Group is one of the top cannabis companies besides Canopy Growth (WEED), Tilray (TLRY), and Aurora Cannabis (ACB) that have dominated in the Canadian market.

CRON and MO versus HMMJ ETF 2019-02-04

Tobacco slowing down

However, Altria has been struggling with weakness in tobacco consumption over the years and has been under pressure to look for a catalyst for growth that would capture the transition from tobacco to an alternative product. According to Altria, cannabis and e-cigarettes are two of those catalysts for the company’s long-term growth.

In its earnings call, the company’s chair and CEO, Howard Willard, stated that the company’s investments in e-cigarette company JUUL and cannabis company Cronos Group, following closing, will give the company new growth opportunities and at the same time income stream diversification. He believes that these investments will drive Altria’s future earnings and dividend growth. He called these two investments “fast-growing adjacent categories.”

Next, we’ll discuss how Altria could help accelerate Cronos Group’s growth.

Must Read

What Analysts Recommend for Aurora Cannabis

As of January 16, Aurora Cannabis's consensus 12-month price target from six analysts is 11.8 Canadian dollars.